
may pm et
summari develop manufactur distribut product servic companion anim
veterinari livestock poultri water test dairi market world-wide
price-to-earnings oper ep
see demand product servic
remain strong see potenti risk associ
loss market share competitor increas
aug ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
pm stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
et cfra maintain
announc today acquir
compani billion reaffirm
previous highlight concern anim
competit given attract press
releas highlight acquisit
abax support strategi deploy capit
high-growth segment
global reach greater financi flexibl
enabl combin entiti chip away
domin share companion
anim diagnost market share
significantli today follow news
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
world-wide oper
senior director
corpor overview inc togeth subsidiari develop manufactur
distribut product servic primarili companion anim veterinari livestock poultri
water test dairi market world-wide compani provid point-of-car veterinari diagnost
product includ instrument consum rapid assay veterinari refer laboratori
diagnost consult servic practic manag system servic digit imag
system veterinarian biolog materi test laboratori anim diagnost instrument
servic biomed research commun also offer diagnost health-monitor food
safeti test product livestock poultri dairi market product test water variou
microbiolog contamin point-of-car electrolyt blood ga analyz use
oper three primari busi segment companion anim group water qualiti
product livestock poultri dairi oper segment contain busi
meet quantit threshold report segment
companion anim group total sale provid veterinarian diagnost capabl
inform manag solut enhanc health well-b pet diagnost
provid diagnost capabl meet veterinarian divers need varieti modal
includ in-clin diagnost solut outsid refer laboratori servic in-clin diagnost
solut compris vetlab suit in-clin chemistri hematolog immunoassay
urinalysi coagul analyz associ proprietari consum product provid real-tim
refer lab qualiti diagnost result broad rang single-us handheld snap rapid assay
test kit provid quick accur conveni point-of-car diagnost test result varieti
companion anim diseas health condit offer commerci refer laboratori diagnost
consult servic veterinarian world-wide compani refer laboratori offer larg
select test diagnost panel detect number diseas state condit
anim includ test run in-clin veterinari practic instrument rapid
assay diagnost imag system captur radiograph imag digit form replac
tradit x-ray film film develop process gener requir use hazard
chemic darkroom
water qualiti product segment provid innov test solut easi rapid
accur detect quantif variou microbiolog paramet water princip
product colilert colisur test simultan detect presenc total
coliform coli water compani water test use govern laboratori water
util privat certifi laboratori test drink water complianc regulatori standard
includ environment protect agenc standard test also use evalu water
use product process exampl beverag pharmaceut applic
evalu bottl water recreat water wastewat water privat well
livestock poultri dairi segment sell diagnost test servic relat
instrument use manag health statu livestock poultri improv bovin
reproduct effici ensur qualiti safeti milk food livestock poultri
diagnost product purchas govern privat laboratori provid test servic
livestock veterinarian produc processor princip livestock poultri diagnost product
includ test bovin viral diarrhea viru porcin reproduct respiratori syndrom
segment sell point-of-car analyz relat consum use human
medic hospit clinic measur electrolyt blood gase acid-bas balanc glucos lactat
blood urea nitrogen ioniz calcium calcul paramet base excess anion
gap opti analyz use primarili emerg room oper room cardiac monitor
area locat time-crit diagnost test perform within hospit set
market profil compet mani compani rang larg human pharmaceut
medic diagnost compani small busi focus anim health companion anim
group primari north american competitor includ antech diagnost unit vca inc abaxi inc
heska corpor zoeti inc electrolyt blood ga analyz market compet
primarili larg human medic diagnost compani radiomet a/ siemen medic
solut diagnost instrument laboratori compani abbott diagnost divis abbott
laboratori roch diagnost corpor
financi experienc revenu growth follow growth
five-year compound annual growth rate revenu total cash short-term
invest stood million end total debt billion
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
bullish sinc april technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
equip sub-industri next month
posit continu view mani product
categori histor recession-resist
expect continu grow growth
procedur rate area view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped steadili improv
see continu recoveri
medic devic tax requir
healthcar reform law went effect
januari temporarili suspend
januari
congress pass stopgap measur includ
suspend medic devic tax anoth
two year tax
slate becom effect januari
decemb congress pass tax cut
job act includ repeal
individu mandat compon
afford act requir
peopl health insur pay fine
effect januari believ repeal
individu mandat result fewer
insur peopl neg impact
equip sub-industri fewer insur
patient would like lead fewer procedur
anticip hospit
largest buyer medic equip would also
advers impact could
pressur sub-industri
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
pressur lower demand certain product
categori affect sale growth also think
 hospit becom cautiou
regard capit budget amid shift
base index
five-year market price perform may
procedur inpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
 composit index year
date april health
declin composit index
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
laboratori inc rais target price
ep estim multipl premium peer reflect
strong sale growth outlook expect modest margin expans aid
oper expens leverag increas ep estim
report oper ep vs
consensu sale increas driven growth
companion anim group see sale growth driven new product
increas diagnost instrument placement /k snyder
inc rais target
ep estim multipl compar
three-year forward averag price-to-earnings reflect slow sale
growth outlook keep ep estim set
report oper ep vs
capit iq consensu driven stronger-than-expect
sale growth oper margin expans organ sale increas
driven growth companion anim group see sale growth
increas diagnost instrument placement /k snyder
analyst research note compani news
et cfra maintain sell rate share
abax nr announc today acquir zoeti
lead anim health compani billion reaffirm
previous highlight concern anim diagnost industri could
becom increasingli competit given attract press releas
highlight acquisit abax support strategi deploy
capit high-growth segment animal-health industri think
sizeabl global reach greater financi flexibl enabl
combin entiti chip away domin share companion anim
diagnost market share significantli today follow news
zts/abax deal /kevin huang cfa
laboratori inc rais target
above-p idxx averag forward pe
ep estim idxx forward pe rang
last five year ep vs
higher estim rais ep
ep sale increas
organ million driven growth organ
companion anim group busi sale idxx
latest product sdma test kidney function gener avail
first full quarter saw adopt north american catalyst
diagnost tool custom see import driver futur revenu
growth although impress idxx innov increas
sale exist custom think stock overvalu base
price-to-earnings multipl discount cash flow dcf basi /kevin huang
laboratori keep target
ep estim compar ten-year forward averag price-to-earnings
reflect stabl sale growth outlook rais ep
estim mostli driven tax reform set
estim report oper ep
vs consensu sale increas growth
segment driven growth vetlab consum expect
sale growth driven steadi growth refer laboratori
diagnost consult servic /keith snyder
laboratori inc rais target
ep estim premium peer line
three-year forward averag price-to-earnings reflect stabl organ sale growth
improv margin level driven increas recur revenu rais
ep estim
report oper ep vs consensu
sale increas driven growth segment see
sale growth strong recur revenu growth addit
laboratori inc keep target price
ep estim premium peer reflect
improv sale growth outlook expect margin expans aid
product mix shift moder price increas rais
ep estim report
oper ep vs consensu sale
increas driven growth segment strong increas
consum refer lab servic expect sale growth
aid gain market /k snyder
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
